Dynamics of Glucose Metabolism After Kidney Transplantation

Background/Aims: Posttransplantation diabetes mellitus (PTDM) impacts patient and allograft survival after kidney transplantation. Prediabetes, which is an independent risk factor for PTDM, is modifiable also in a post-transplant setting. Understanding the risks and dynamics of impaired glucose metabolism after transplantation is a key component for targeted intervention. Methods: A retrospective chart analysis of all adult non-diabetic renal allograft recipients (n=251, 2007-2014) was performed. Longitudinal follow-up included fasting plasma glucose and HbA1c, as well as data on allograft function and immunosuppression at consecutive time points (months 3-6 to >5 years post transplantation). Results: Throughout follow-up, median prevalence of prediabetes and PTDM was 53.3 [52.4-55.7]% and 15.4 [15.0-16.5]%, respectively. Continuously high fluxes between states of glucose metabolism, with individual patients’ state deteriorating or improving over time, resulted in a high number of incident patients even long after transplantation. The greatest number of patients shifted between normal glucose tolerance and prediabetes, followed by those between prediabetes and PTDM. Conclusion: Prediabetes and PTDM are highly prevalent after kidney transplantation and incidences remain relevant throughout follow-up. Patient fluxes into and out of the prediabetic state show that glucose metabolism is highly dynamic after transplantation. This provides a continuous opportunity for intervention in an aim to reduce diabetes-associated complications.

• Publication year

  2017

• Venue

  Kidney & Blood Pressure Research

• Publication date

  2017-09-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000481375PMID 28930756
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis and Classification of Diabetes Mellitus

  2019cited by this paper
• Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival

  2017cited by this paper
• Clinical evolution of post-transplant diabetes mellitus.

  2016cited by this paper
• Phenotypes of prediabetes and stratification of cardiometabolic risk.

  2016cited by this paper
• Novel phenotypes of prediabetes?

  2016cited by this paper
• Long‐term patient survival and kidney allograft survival in post‐transplant diabetes mellitus: a single‐center retrospective study

  2016cited by this paper
• Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.

  2016cited by this paper
• Mortality risk in post‐transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria

  2016cited by this paper
• Comparison of the Estimated Glomerular Filtration Rate (eGFR) in Diabetic Patients, Non-Diabetic Patients and Living Kidney Donors

  2016cited by this paper
• Diabetes Mellitus and Prediabetes on Kidney Transplant Waiting List- Prevalence, Metabolic Phenotyping and Risk Stratification Approach

  2015cited by this paper
• Role of glycated hemoglobin in the screening and diagnosis of posttransplantation diabetes mellitus after renal transplantation: A diagnostic accuracy study.

  2015cited by this paper
• Antidiabetic therapy in post kidney transplantation diabetes mellitus.

  2015cited by this paper
• Genetics of new-onset diabetes after transplantation.

  2014cited by this paper
• Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions

  2014cited by this paper
• Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German Center for Diabetes Research

  2013cited by this paper
• Glucose Metabolism After Renal Transplantation

  2013cited by this paper
• Screening for New-Onset Diabetes After Kidney Transplantation: Limitations of Fasting Glucose and Advantages of Afternoon Glucose and Glycated Hemoglobin

  2013cited by this paper
• Early basal insulin therapy decreases new-onset diabetes after renal transplantation.

  2012cited by this paper
• Renal Function and NODM in De Novo Renal Transplant Recipients Treated with Standard and Reduced Levels of Tacrolimus in Combination with EC-MPS

  2012cited by this paper
• Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus

  2012cited by this paper
• Prevalence and risk factors of pre-diabetes after renal transplantation: a single-centre cohort study in 200 consecutive patients.

  2012cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• New onset diabetes after transplantation (NODAT): an overview

  2011cited by this paper
• Incidence and Risk Factors of Glucose Metabolism Disorders in Kidney Transplant Recipients: Role of Systematic Screening by Oral Glucose Tolerance Test

  2011cited by this paper
• Diagnostic Value of Hemoglobin A1c for Type 2 Diabetes Mellitus in a Population at Risk

  2011cited by this paper
• Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation

  2011cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2010cited by this paper
• A Systematic Review on Steroid Withdrawal Between 3 and 6 Months After Kidney Transplantation

  2010cited by this paper
• Diagnostic application of the A(1c) assay in renal disease.

  2010cited by this paper
• Pathomechanisms of type 2 diabetes genes.

  2009cited by this paper
• Novel insights into glucocorticoid‐mediated diabetogenic effects: towards expansion of therapeutic options?

  2009cited by this paper
• Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival.

  2008cited by this paper
• Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care

  2008cited by this paper
• Influence of Lifestyle Modification in Renal Transplant Recipients With Postprandial Hyperglycemia

  2008cited by this paper
• Predictors of new onset diabetes after renal transplantation

  2007cited by this paper
• Conversion from tacrolimus to cyclosporine A for new‐onset diabetes after transplantation: a single‐centre experience in renal transplanted patients and review of the literature

  2007cited by this paper
• Impaired Fasting Glucose and Impaired Glucose Tolerance

  2007cited by this paper
• Diabetic Complications Associated With New-Onset Diabetes Mellitus in Renal Transplant Recipients

  2007cited by this paper
• Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.

  2007cited by this paper
• Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

  2007cited by this paper
• Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function

  2006cited by this paper
• Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function.

  2006cited by this paper
• New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta‐Analysis

  2004cited by this paper
• A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients.

  2003cited by this paper
• Diabetes Mellitus after Kidney Transplantation in the United States

  2003cited by this paper
• Diabetes Mellitus After Kidney Transplantation in the United States

  2003cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus.

  2001cited by this paper
• Global and societal implications of the diabetes epidemic

  2001cited by this paper
• Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.

  2001cited by this paper
• β-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus

  2001cited by this paper
• A simplified equation to predict glomerular filtration rate from serum creatinine

  2000cited by this paper
• Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients.

  1998cited by this paper
• Parental History of Diabetes in a Population-Based Study

  1996cited by this paper
• Risk of Diabetes in Offspring of Parents with Non‐insulin‐dependent Diabetes

  1995cited by this paper
• Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.

  1992cited by this paper

• Innovative Trajectory Analysis Reveals Dynamics and Risk Factors of Post‐Kidney Transplant Diabetes Mellitus in a French Cohort

  2025cites this paper
• Differential risk assessment in persons at risk of type 2 diabetes using urinary peptidomics.

  2025cites this paper
• Normalization of impaired glucose tolerance after kidney transplantation is associated with improved beta-cell function.

  2024cites this paper
• International consensus on post-transplantation diabetes mellitus

  2024cites this paper
• Interventions Against Posttransplantation Diabetes: A Scientific Rationale for Treatment Hierarchy Based on Literature Review.

  2022cites this paper
• Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study

  2022cites this paper
• Dynamics of glucose metabolism after liver transplantation: prediabetes as a window of opportunity for patient survival and long‐term kidney function

  2021cites this paper
• Global Epidemiology, Health Outcomes, and Treatment Options for Patients With Type 2 Diabetes and Kidney Failure

  2021cites this paper
• Institutional Experience With New Antidiabetic Drugs in Kidney Transplant.

  2021cites this paper
• Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics

  2020cites this paper
• Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the Italian Diabetes Society (SID).

  2020cites this paper
• Risk factors for hyperglycemia in kidney transplant patients

  2020cites this paper
• Transplantation and diabetes (Transdiab): a pilot randomised controlled trial of metformin in impaired glucose tolerance after kidney transplantation

  2019cites this paper
• Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus

  2019cites this paper
• HbA1c levels at 90 days after renal transplantation in non-diabetic recipients predict de novo pre-diabetes and diabetes at 1 and 3 years after transplantation

  2018cites this paper
• Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017

  2018cites this paper
• Diabetes mellitus vor und nach Nierentransplantation

  2018influential citation